Thioctic Acid + Placebo
Phase 3Completed 0 views this week 0 watching💤 Quiet
Interest: 37/100
37
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Diabetic Polyneuropathy
Conditions
Diabetic Polyneuropathy
Trial Timeline
May 1, 1998 → Jan 1, 2005
NCT ID
NCT00977483About Thioctic Acid + Placebo
Thioctic Acid + Placebo is a phase 3 stage product being developed by Viatris for Diabetic Polyneuropathy. The current trial status is completed. This product is registered under clinical trial identifier NCT00977483. Target conditions include Diabetic Polyneuropathy.
What happened to similar drugs?
20 of 20 similar drugs in Diabetic Polyneuropathy were approved
Approved (20) Terminated (3) Active (0)
Hype Score Breakdown
Clinical
17
Activity
8
Company
12
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00977483 | Phase 3 | Completed |
Competing Products
20 competing products in Diabetic Polyneuropathy